These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3169232)

  • 1. New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity.
    Brennan SO; Borg JY; George PM; Soria C; Soria J; Caen J; Carrell RW
    FEBS Lett; 1988 Sep; 237(1-2):118-22. PubMed ID: 3169232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135.
    Brennan SO; George PM; Jordan RE
    FEBS Lett; 1987 Jul; 219(2):431-6. PubMed ID: 3609301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin-heparin affinity reduced by fucosylation of carbohydrate at asparagine 155.
    Garone L; Edmunds T; Hanson E; Bernasconi R; Huntington JA; Meagher JL; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(27):8881-9. PubMed ID: 8688424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
    Picard V; Ersdal-Badju E; Bock SC
    Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.
    Ersdal-Badju E; Lu A; Peng X; Picard V; Zendehrouh P; Turk B; Björk I; Olson ST; Bock SC
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):323-30. PubMed ID: 7646463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding.
    Peterson CB; Blackburn MN
    J Biol Chem; 1985 Jan; 260(1):610-5. PubMed ID: 3965464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.
    Owen MC; Borg JY; Soria C; Soria J; Caen J; Carrell RW
    Blood; 1987 May; 69(5):1275-9. PubMed ID: 3567355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin.
    Aguila S; Martínez-Martínez I; Dichiara G; Gutiérrez-Gallego R; Navarro-Fernández J; Vicente V; Corral J
    PLoS One; 2014; 9(12):e114454. PubMed ID: 25485983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F.
    Olds RJ; Lane DA; Boisclair M; Sas G; Bock SC; Thein SL
    FEBS Lett; 1992 Apr; 300(3):241-6. PubMed ID: 1555650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glycosylation on heparin binding and antithrombin activation by heparin.
    Pol-Fachin L; Franco Becker C; Almeida Guimarães J; Verli H
    Proteins; 2011 Sep; 79(9):2735-45. PubMed ID: 21769943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
    Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial overexpression of beta antithrombin caused by an Asn135Thr substitution.
    Bayston TA; Tripodi A; Mannucci PM; Thompson E; Ireland H; Fitches AC; Hananeia L; Olds RJ; Lane DA
    Blood; 1999 Jun; 93(12):4242-7. PubMed ID: 10361121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA; Gettins PG
    Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of recombinant human antithrombin III expressed in baby hamster kidney cells. Effect of glycosylation differences on heparin binding and structure.
    Fan B; Crews BC; Turko IV; Choay J; Zettlmeissl G; Gettins P
    J Biol Chem; 1993 Aug; 268(23):17588-96. PubMed ID: 8349638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.
    Martínez-Martínez I; Navarro-Fernández J; Østergaard A; Gutiérrez-Gallego R; Padilla J; Bohdan N; Miñano A; Pascual C; Martínez C; de la Morena-Barrio ME; Aguila S; Pedersen S; Kristensen SR; Vicente V; Corral J
    Blood; 2012 Jul; 120(4):900-4. PubMed ID: 22498748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.
    Watton J; Longstaff C; Lane DA; Barrowcliffe TW
    Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.